Why Biotechnology Investing is Looking Healthy

ETF Trends publisher Tom Lydon discussed SPDR S&P Biotech ETF (NYSEArca:XBI) on this week’s “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show. Deregulation/tax cuts from the Trump administration could help large biotechs accumulate more cash, which in turn could help fuel merger & acquisition activity in an ongoing low-rate environment. XBI tracks a…Click to read more at ETFtrends.com.